Buchweitz J, Raverty S, Johnson M, Lehner A
Can Vet J. 2014; 55(11):1089-92.
PMID: 25392554
PMC: 4204843.
Ikeda-Sagara M, Ozaki T, Shahid M, Morioka E, Wada K, Honda K
Br J Pharmacol. 2011; 165(1):167-82.
PMID: 21699505
PMC: 3252975.
DOI: 10.1111/j.1476-5381.2011.01547.x.
Thakkar M
Sleep Med Rev. 2010; 15(1):65-74.
PMID: 20851648
PMC: 3016451.
DOI: 10.1016/j.smrv.2010.06.004.
Richards D, Brogden R, Heel R, Speight T, Avery G
Drugs. 1984; 28(1):38-61.
PMID: 6204835
DOI: 10.2165/00003495-198428010-00003.
Monti J, Pellejero T, Jantos H
J Neural Transm. 1986; 66(1):1-11.
PMID: 3734773
DOI: 10.1007/BF01262953.
Effects of a-fluoromethylhistidine on sleep and wakefulness in the rat. Short note.
Monti J, DAngelo L, Jantos H, Pazos S
J Neural Transm. 1988; 72(2):141-5.
PMID: 3385425
DOI: 10.1007/BF01250237.
Behavioural effects of histamine and its antagonists: a review.
White J, Rumbold G
Psychopharmacology (Berl). 1988; 95(1):1-14.
PMID: 3133686
DOI: 10.1007/BF00212757.
Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor.
Wauquier A, Van Belle H, Van den Broeck W, Janssen P
Psychopharmacology (Berl). 1987; 91(4):434-9.
PMID: 3108923
DOI: 10.1007/BF00216007.
Comparison of the central and peripheral effects of cetirizine and terfenadine.
Pechadre J, Vernay D, Trolese J, Bloom M, Dupont P, Rihoux J
Eur J Clin Pharmacol. 1988; 35(3):255-9.
PMID: 2903059
DOI: 10.1007/BF00558262.
Influence of certain H1-blockers on the step-through active avoidance response in rats.
Kamei C, Chung Y, Tasaka K
Psychopharmacology (Berl). 1990; 102(3):312-8.
PMID: 1979177
DOI: 10.1007/BF02244096.
Plenary lecture. A third histamine receptor subtype: characterisation, localisation and functions of the H3-receptor.
Schwartz J, Arrang J, Garbarg M, Pollard H
Agents Actions. 1990; 30(1-2):13-23.
PMID: 1695431
DOI: 10.1007/BF01968988.
